Adrienne T.A. Box
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Adrienne T.A. Box.
The Journal of Infectious Diseases | 2002
Maurine A. Leverstein-van Hall; Adrienne T.A. Box; Hetty E. M. Blok; Armand Paauw; Ad C. Fluit; Jan Verhoef
Multidrug resistance in gram-negative bacteria appears to be primarily the result of the acquisition of resistance genes by horizontal transfer. To what extent horizontal transfer may be responsible for the emergence of multidrug resistance in a clinical setting, however, has rarely been investigated. Therefore, the integron contents of isolates collected during a nosocomial outbreak of genotypically unrelated multidrug-resistant Enterobacteriaceae were characterized. The integron was chosen as a marker of transfer because of its association with multiresistance. Some genotypically identical isolates harbored different integrons. Grouping patients carrying the same integron yielded 6 epidemiologically linked clusters, with each cluster representing a different integron. Several patients carried multiple species harboring the same integron. Conjugation experiments with these strains resulted in the transfer of complete resistance patterns at high frequencies (10(-2) to 10(-4)). These findings provide strong evidence that the horizontal transfer of resistance genes contributed largely to the emergence of multidrug-resistant Enterobacteriaceae in this clinical setting.
Journal of Clinical Microbiology | 2002
M. A. Leverstein-van Hall; Armand Paauw; Adrienne T.A. Box; Hetty E. M. Blok; Jan Verhoef; A. C. Fluit
ABSTRACT Integrons are strongly associated with the multidrug resistance seen in gram-negative bacilli in the hospital environment. No data, however, are available on their prevalence in the community. This study is the first to show that integrons are widespread in Enterobacteriaceae in the community and that integron-associated resistance genes in the community constitute a substantial reservoir for multidrug resistance in the hospital.
Journal of Clinical Microbiology | 2002
Maurine A. Leverstein-van Hall; Ad C. Fluit; Armand Paauw; Adrienne T.A. Box; Sylvain Brisse; Jan Verhoef
ABSTRACT Seventy-four isolates of multiresistant Escherichia coli and Klebsiella spp. recovered during a 3-year period and 17 control strains with genotypically identified beta-lactamases were tested for the production of extended-spectrum beta-lactamases (ESBLs) by using the Etest and the VITEK 1, VITEK 2, and Phoenix automated instruments. The use of the Etest was evaluated by investigating its accuracy in detecting the ESBLs of the control strains and by comparing interpretation results of laboratory technicians and experts. The accuracy of the Etest was 94%. With the Etest as the reference for the clinical strains and the genotype as the reference for the control strains, the automated instruments detected the ESBLs with accuracies of 78% (VITEK 2), 83% (VITEK 1), and 89% (Phoenix). No significant difference between the systems with regard to the control strains was detected. The VITEK 2 did, however, perform less well than the Phoenix (P = 0.03) on the collection of clinical isolates, mainly because of its high percentage of indeterminate test results (11%). No significant difference between the performances of the VITEK 1 and either the VITEK 2 or the Phoenix was found. However, because of its associated BDXpert system the Phoenix showed the best performance. The Etest was found to be an accurate test but was limited by its indeterminate results (4%), its inability to differentiate between K1 hyperproduction and ESBLs, questionable guidelines concerning mutants inside the inhibition zones, and the inability of the technicians to recognize subtle zone deformations.
Antimicrobial Agents and Chemotherapy | 2001
E. D. J. Peters; M. A. Leverstein-van Hall; Adrienne T.A. Box; Jan Verhoef; A. C. Fluit
ABSTRACT An increase in multiresistant Enterobacteriaceae was observed at one of the departments of the University Medical Center Utrecht. Nine different integrons and 17 gene cassettes were found, including the new gene cassette aadA8. This cassette was highly related to aadA3 and aadA2. In addition, an unknown promoter sequence was found for two integrons.
Journal of Microbiological Methods | 1999
Myra N. Widjojoatmodjo; Annemarie Borst; R Schukkink; Adrienne T.A. Box; Nicole M. M. Tacken; Bob van Gemen; Jan Verhoef; Bert Top; Ad C. Fluit
Nucleic Acid Sequence Based Amplification (iNASBA), an isothermal amplification technique for nucleic acids, was evaluated for the identification of medically important Candida species using primers selected from 18S rRNA sequences conserved in fungi. An RNA fragment of 257 nucleotides was amplified for Candida albicans. Nineteen different fungi were tested for rRNA amplification with the NASBA. All were positive when analyzed on agarose gel, whereas human RNA was negative. For the identification of Candida species, NASBA amplification products were analyzed in an enzyme bead-based detection format, using species-specific biotinylated probes and a generic Candida HRPO probe or a membrane-based system using biotinylated probes and avidin-HPRO. Discrimination of the major human pathogenic Candida spp. was based on a panel of biotinylated probes for C. krusei, C. tropicalis, C. albicans, C. glabrata, and C. lusitaniae. Using rRNA dilutions obtained from pure cultures of C. albicans, the combination of NASBA and the enzymatic bead-based detection yielded a sensitivity equivalent to 0.01 CFU. In a model system using 1 ml of artificially contaminated blood as few as 1-10 CFU of C. albicans could be detected. Testing of 68 clinical blood samples from patients suspected of candidemia showed that eight samples were positive for C. albicans and one for C. glabrata. Testing of 13 clinical plasma samples from patients suspected of fungemia identified the presence of C. albicans in two specimens. The whole procedure of sample preparation, amplification and identification by hybridization can be performed in 1 day. This speed and the observed sensitivity of the assay make the NASBA a good alternative to PCR for the detection of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases | 2001
M.A. Leverstein-van Hall; A. C. Fluit; Hetty E. M. Blok; Adrienne T.A. Box; E. D. J. Peters; A. J. L. Weersink; Jan Verhoef
Abstract. An observational study on the epidemiology of multiresistant Enterobacteriaceae was conducted in the neurology and neurosurgery wards of a university hospital to determine the impact of hospital hygiene measures and an additional temporary restrictive antibiotic agent policy on the sudden rise in incidence of these bacteria. The incidence and prevalence of patients with multiresistant Enterobacteriaceae were assessed, and patient isolates were typed phenotypically and by random amplified polymorphic DNA analysis. All hospital hygiene measures implemented were recorded, and the influence of the restrictive policy on antibiotic use was analyzed. This policy consisted of a prior authorization requirement and the withdrawal of all antibiotics with a possible selective pressure on multiresistant strains (gentamicin, tobramycin, quinolones, cotrimoxazole, broad-spectrum penicillins, and cephalosporins). This ban left only carbapenems and amikacin for treatment. Typing showed that 17 of the 61 (28%) patients involved were infected or colonized with a single multiresistant strain of Klebsiella oxytoca, for which an environmental source was identified. The isolates recovered from the other patients comprised eight different species, and subsequent genotyping yielded a great variety of strains. The increased incidence could not be controlled with hospital hygiene measures alone. Only after implementation of the restrictive antibiotic policy did the epidemic strain vanish and the endemic incidence of multiresistant Enterobacteriaceae decrease to <50% of the level before intervention. In the years since, the incidence has remained at this low level, and the antibiotic costs have decreased to a level lower than before intervention.
Journal of Clinical Microbiology | 2008
Risma Ikawaty; Rob J. L. Willems; Adrienne T.A. Box; Jan Verhoef; Ad C. Fluit
ABSTRACT We evaluated the use of a novel multiple-locus variable-number tandem-repeat analysis (MLVA) method for typing of human Staphylococcus aureus. For a total of 150 clinical isolates, MLVA demonstrated the highest discriminatory power. MLVA correctly assigned isolates to outbreaks or identified isolates as unlinked. MLVA is a rapid and simple method for the epidemiological typing of S. aureus.
Emerging Infectious Diseases | 2009
Marc D. Jansen; Adrienne T.A. Box; Ad C. Fluit
We thank Jansen et al. for their comments about the SCCmec types of sequence type (ST) 398 methicillin-resistant Staphylococcus aureus (MRSA) isolates (1). For SCCmec typing of MRSA, several different PCR methods have been published. We originally chose the SCCmec PCR developed by Zhang et al. (2) because at that time it was the method of choice in many published papers. Fluit et al. questioned whether the SCCmec type III isolates were correctly typed (1). To prove that the results of typing these 4 isolates were incorrect, these researchers performed several different SCCmec PCRs, including a PCR with primers they developed themselves. In addition, Southern hybridization was done. The results showed that SCCmec III ST398 MRSA isolates should be typed as SCCmec type V. In this conclusion we agree with the authors. It seems clear that Zhang’s method incorrectly identified 4 of the animal-related ST398 isolates as SCCmec type III instead of SCCmec type V. Whether all ST398 MRSA are SCCmec type IV or V remains unclear. Recently, an article by Nemati et al. was published in which ST398 MRSA was also typed as SCCmec III (3). However, in that study the SCCmec typing method of Zhang was also used. In conclusion, the choice of SCCmec typing method is directly related to obtaining accurate SCCmec results for ST398 isolates. To date, almost all animal-related ST398 MRSA isolates are SCCmec types IV and V.
Veterinary Microbiology | 2004
E. van Duijkeren; Adrienne T.A. Box; M Heck; W. J. B. Wannet; Ad C. Fluit
Microbial Drug Resistance | 2005
Adrienne T.A. Box; Dik Mevius; Pepijn Schellen; Jan Verhoef; Ad C. Fluit